Speech-Language Pathologists in Germantown, NY Accepting Medicare

4 Speech-Language Pathologists found. Showing 1 - 4

Cornelia Mcgiver, MS SLP CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 82 Block Factory Rd, Germantown, NY 12526 Phone: 914-388-2516

Shirley T. Dorion, M.S.ED., CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 123 Main St, Germantown, NY 12526 Phone: 518-537-6281    Fax: 518-537-6284

Jennie Claire Portney, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1123 County Route 6, Germantown, NY 12526 Phone: 610-246-4651

Mrs. Dana Balzer Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 123 Main St, Germantown, NY 12526 Phone: 518-537-6281

News Archive

Beryl redefines focus as patient experience company

Beryl, the leader and pioneer in outsourced healthcare contact center services, announces its redefined focus as a patient experience company. For 25 years, Beryl has focused on making it easier for patients to access information and healthcare providers, which enhances patients' interactions with healthcare systems. While this underlying theme has always been present, redefining its focus ensures that all of Beryl's products and services are developed with a laser focus on their impact on improving the patient experience in healthcare.

Promedior raises $12M in Series C financing

Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat inflammatory and fibrotic diseases, today announced that it has raised $12 million in a Series C financing round. Forbion Capital Partners led the round, with participation from existing investors Morgenthaler Ventures, HealthCare Ventures, Polaris Venture Partners, and Easton Capital. The Series C financing brings the total capital raised by Promedior over the past year to $27 million.

Martek Biosciences resolves patent dispute with Capsugel France

DHA omega-3 innovator and maker of the life'sDHA(TM) brand, Martek Biosciences Corporation (Nasdaq: MATK), announced today it has resolved a patent dispute with Capsugel France. The resolution follows Martek's November 2008 action for infringement filed in the High Court of Strasbourg, France.

Study suggests three-week course of radiation therapy effective for breast cancer patients

According to a study presented November 4, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO), a shortened, more intensive course of radiation given to the whole breast, along with an extra dose of radiation given to the surgical bed of the tumor (concomitant boost), has been shown to result in excellent local control at a median follow up of two years after treatment with no significant side effects.

Georgia Tech and Emory University receive $4 million grant to establish HERCULES Center

Investigators at Rollins School of Public Health at Emory University, along with partners at the Georgia Institute of Technology, have received a $4 million grant over four years to establish the HERCULES Center at Emory University (Health and Exposome Research Center: Understanding Lifetime Exposures). The grant is the first exposome-based center grant awarded in the United States.

Read more Medical News

› Verified 3 days ago